Search research articles
Contact Us
Filters
Showing results (181-190 of 199) with videos related to
Page
of 20
Sort By:
Journal of Medicinal Chemistry
|
March 4, 2008
Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity
Jennifer M Frost, Michael J Dart, Karin R Tietje, et al.
Cell
|
September 20, 2016
Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments
Rafael Di Marco Barros, Natalie A Roberts, Robin J Dart, et al.
British Journal of Pharmacology
|
November 13, 2007
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models
B B Yao, G C Hsieh, J M Frost, et al.
British Journal of Pharmacology
|
October 30, 2007
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI
C-L Chin, A E Tovcimak, V P Hradil, et al.
Journal of Medicinal Chemistry
|
June 26, 2007
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors
William H Bunnelle, Jerome F Daanen, Keith B Ryther, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management
Derek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Elife
|
January 10, 2019
eIF2B activator prevents neurological defects caused by a chronic integrated stress response
Yao Liang Wong, Lauren LeBon, Ana M Basso, et al.
Science Translational Medicine
|
July 19, 2019
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
Rachael M Zemek, Emma De Jong, Wee Loong Chin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging
Betty B Yao, Gin Hsieh, Anthony V Daza, et al.
Journal of Medicinal Chemistry
|
May 19, 2026
Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human Studies
Jennifer M Frost, Yunsong Tong, Xiangdong Xu, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 199) with videos related to
Sort By:
Page
of 20
Journal of Medicinal Chemistry
|
March 4, 2008
Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity
Jennifer M Frost, Michael J Dart, Karin R Tietje, et al.
Cell
|
September 20, 2016
Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments
Rafael Di Marco Barros, Natalie A Roberts, Robin J Dart, et al.
British Journal of Pharmacology
|
November 13, 2007
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models
B B Yao, G C Hsieh, J M Frost, et al.
British Journal of Pharmacology
|
October 30, 2007
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI
C-L Chin, A E Tovcimak, V P Hradil, et al.
Journal of Medicinal Chemistry
|
June 26, 2007
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors
William H Bunnelle, Jerome F Daanen, Keith B Ryther, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management
Derek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Elife
|
January 10, 2019
eIF2B activator prevents neurological defects caused by a chronic integrated stress response
Yao Liang Wong, Lauren LeBon, Ana M Basso, et al.
Science Translational Medicine
|
July 19, 2019
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
Rachael M Zemek, Emma De Jong, Wee Loong Chin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging
Betty B Yao, Gin Hsieh, Anthony V Daza, et al.
Journal of Medicinal Chemistry
|
May 19, 2026
Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human Studies
Jennifer M Frost, Yunsong Tong, Xiangdong Xu, et al.
Page
of 20